1. Early worsening of diabetic retinopathy due to intensive glycaemic control.
- Author
-
Lim SW, van Wijngaarden P, Harper CA, and Al-Qureshi SH
- Subjects
- Angiogenesis Inhibitors therapeutic use, Bevacizumab therapeutic use, Blood Glucose metabolism, Diabetes Mellitus, Type 2 physiopathology, Diabetic Retinopathy diagnosis, Diabetic Retinopathy drug therapy, Fluorescein Angiography, Glycated Hemoglobin metabolism, Humans, Intravitreal Injections, Male, Middle Aged, Tomography, Optical Coherence, Vascular Endothelial Growth Factor A antagonists & inhibitors, Visual Acuity physiology, Diabetic Retinopathy physiopathology, Glycemic Index physiology
- Abstract
The prevalence of diabetes and diabetic retinopathy is increasing around the world. Glycaemic control is important in reducing the long-term risk of complications of diabetes, however intensive glycaemic control, particularly in patients with longstanding and poorly controlled diabetes, is associated with the risk of early worsening of diabetic retinopathy and vision loss. We present two clinical cases to illustrate the presentation of early worsening and to highlight a role for intravitreal anti-vascular endothelial growth factor therapies in ameliorating this phenomenon, as well as a review of the current understanding of this phenomenon. We emphasise the importance of identifying individuals at risk of early worsening of diabetic retinopathy and recommend regular ophthalmological review during the period of intensive glycaemic control to ensure optimal visual outcomes., (© 2018 Royal Australian and New Zealand College of Ophthalmologists.)
- Published
- 2019
- Full Text
- View/download PDF